The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
The Role of Astrocytes in Multiple Sclerosis Progression
Open accessAbstract
Multiple sclerosis (MS) is an inflammatory disorder causing central nervous system (CNS) demyelination and axonal injury. Although its etiology remains elusive, several lines of evidence support the concept that autoimmunity plays a major role in disease pathogenesis. The course of MS is highly variable; nevertheless, the majority of patients initially present a relapsing-remitting clinical course. After 10-15 years of disease, this pattern becomes progressive in up to 50% of untreated patients, during which time clinical symptoms slowly cause constant deterioration over a period of many years. In about 15% of MS patients, however, disease progression is relentless from disease onset. Published evidence supports the concept that progressive MS reflects a poorly understood mechanism of insidious axonal degeneration and neuronal loss. Recently, the type of microglial cell and of astrocyte activation and proliferation observed has suggested contribution of resident CNS cells may play a critical role in disease progression. Astrocytes could contribute to this process through several mechanisms: (a) as part of the innate immune system, (b) as a source of cytotoxic factors, (c) inhibiting remyelination and axonal regeneration by forming a glial scar, and (d) contributing to axonal mitochondrial dysfunction. Furthermore, regulatory mechanisms mediated by astrocytes can be affected by aging. Notably, astrocytes might also limit the detrimental effects of pro-inflammatory factors, while providing support and protection for oligodendrocytes and neurons. Because of the dichotomy observed in astrocytic effects, the design of therapeutic strategies targeting astrocytes becomes a challenging endeavor. Better knowledge of molecular and functional properties of astrocytes, therefore, should promote understanding of their specific role in MS pathophysiology, and consequently lead to development of novel and more successful therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
New Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Regeneration beyond the glial scar
Silver, J., & Miller, J. H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1326 · Cited by 3,078
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Chondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Signaling in innate immunity and inflammation
Newton, K., & Dixit, V. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006049 · Cited by 1,513 · cited 1×
“Cellular innate immune responses to diverse stimuli are accomplished through an array of pattern recognition receptors (PRRs) that bind to diverse pathogen-associated molecular patterns (PAMPs) (40).”
BackgroundGlial inhibition of CNS axon regeneration
Yiu, G., & He, Z. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1956 · Cited by 1,495
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Control of Synapse Number by Glia
Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., & Barres, B. A. (2001) · Science · doi:10.1126/science.291.5504.657 · Cited by 1,380
Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)
Eng, L. F., Ghirnikar, R. S., & Lee, Y. L. (2000) · Neurochemical Research · doi:10.1023/a:1007677003387 · Cited by 1,369
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 1×
“Astrocytes express diverse PRRs, and can mediate innate immune responses through several mechanisms (10, 42).”
BackgroundDong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
Pathological mechanisms in progressive multiple sclerosis
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,137
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Okada, S., Nakamura, M., Katoh, H., Miyao, T., Shimazaki, T., Ishii, K., Yamane, J., Yoshimura, A., Iwamoto, Y., Toyama, Y., et al. (2006) · Nature Medicine · doi:10.1038/nm1425 · Cited by 968
STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury
Herrmann, J. E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T. K., Korsak, R. A., Takeda, K., Akira, S., & Sofroniew, M. V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1709-08.2008 · Cited by 958 · cited 2×
“Similarly, GFAP or nestin promoter ablation of STAT3 in astrocytes attenuated upregulation of GFAP, reduced astrocytes hypertrophy, limited astrocyte migration, and led to more widespread infiltration of CD11b+ inflammatory cells, associated with larger lesions and more prominent impairment (100, 101).”
BackgroundAstrocyte-mediated potentiation of inhibitory synaptic transmission
Kang, J., Jiang, L., Goldman, S. A., & Nedergaard, M. (1998) · Nature Neuroscience · doi:10.1038/3684 · Cited by 842
Astrocyte dysfunction in neurological disorders: a molecular perspective
Seifert, G., Schilling, K., & Steinhäuser, C. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1870 · Cited by 799
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease
Argaw, A. T., Asp, L., Zhang, J., Navrazhina, K., Pham, T., Mariani, J. N., Mahase, S., Dutta, D. J., Seto, J., Kramer, E. G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60842 · Cited by 733
Bal-Price, A., & Brown, G. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06480.2001 · Cited by 686
NG2 cells generate both oligodendrocytes and gray matter astrocytes
Zhu, X., Bergles, D. E., & Nishiyama, A. (2008) · Development · doi:10.1242/dev.004895 · Cited by 683
Astrocytes and disease: a neurodevelopmental perspective
Molofsky, A. V., Krenick, R., Ullian, E., Tsai, H.-H., Deneen, B., Richardson, W. D., Barres, B. A., & Rowitch, D. H. (2012) · Genes & Development · doi:10.1101/gad.188326.112 · Cited by 682
VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown
Argaw, A. T., Gurfein, B. T., Zhang, Y., Zameer, A., & John, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808698106 · Cited by 666
Blood-brain barrier disruption in multiple sclerosis
Minagar, A., & Alexander, J. S. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms965oa · Cited by 638
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation
Back, S. A., Tuohy, T. M. F., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N. L., Banine, F., Liu, Y., Chang, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1279 · Cited by 612 · cited 1×
“Oligodendrocytes that co-localize with hyaluronan express an immature phenotype, and treatment of OPCs with hyaluronan in vitro prevents maturation (109).”
BackgroundNeurorestorative therapies for stroke: underlying mechanisms and translation to the clinic
Zhang, Z. G., & Chopp, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70061-4 · Cited by 596 · cited 1×
“For example, reactive astrocytes profoundly affect post-ischemic stages by secreting VEGF, which in turn stimulates formation of new blood vessels and synaptogenesis (97, 98), this beneficial effect contrasts sharply with induction of BBB breakdown and lymphocyte infiltration observed in autoimmune CNS inflammation, w…”
BackgroundSignaling at the Gliovascular Interface
Simard, M., Arcuino, G., Takano, T., Liu, Q. S., & Nedergaard, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09254.2003 · Cited by 586
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
Salter, M. G., & Fern, R. (2005) · Nature · doi:10.1038/nature04301 · Cited by 553
Regional Astrocyte Allocation Regulates CNS Synaptogenesis and Repair
Tsai, H.-H., Li, H., Fuentealba, L. C., Molofsky, A. V., Taveira-Marques, R., Zhuang, H., Tenney, A., Murnen, A. T., Fancy, S. P. J., Merkle, F., et al. (2012) · Science · doi:10.1126/science.1222381 · Cited by 533
The stem cell potential of glia: lessons from reactive gliosis
Robel, S., Berninger, B., & Götz, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2978 · Cited by 515
WANG, D., & BORDEY, A. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.015 · Cited by 502
Krumbholz, M., Theil, D., Derfuss, T., Rosenwald, A., Schrader, F., Monoranu, C.-M., Kalled, S. L., Hess, D. M., Serafini, B., Aloisi, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041674 · Cited by 492
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
Mayo, L., Trauger, S. A., Blain, M., Nadeau, M., Patel, B., Alvarez, J. I., Mascanfroni, I. D., Yeste, A., Kivisäkk, P., Kallas, K., et al. (2014) · Nature Medicine · doi:10.1038/nm.3681 · Cited by 472
Mitochondrial changes within axons in multiple sclerosis
Mahad, D. J., Ziabreva, I., Campbell, G., Lax, N., White, K., Hanson, P. S., Lassmann, H., & Turnbull, D. M. (2009) · Brain · doi:10.1093/brain/awp046 · Cited by 454
DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling
Fan, G., Martinowich, K., Chin, M. H., He, F., Fouse, S. D., Hutnick, L., Hattori, D., Ge, W., Shen, Y., Wu, H., et al. (2005) · Development · doi:10.1242/dev.01912 · Cited by 417
Gunter, T. E., Yule, D. I., Gunter, K. K., Eliseev, R. A., & Salter, J. D. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.071 · Cited by 407
Matute, C., Torre, I., Pérez-Cerdá, F., Pérez-Samartín, A., Alberdi, E., Etxebarria, E., Arranz, A. M., Ravid, R., Rodríguez-Antigüedad, A., Sánchez-Gómez, M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0579-07.2007 · Cited by 405
Ephrin-A5 Induces Collapse of Growth Cones by Activating Rho and Rho Kinase
Wahl, S., Barth, H., Ciossek, T., Aktories, K., & Mueller, B. K. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.2.263 · Cited by 392
Sobel, R. A., Mitchell, M. E., & Fondren, G. (1990) · Europe PMC (PubMed Central) · Cited by 388
Angiogenesis after cerebral ischemia
Beck, H., & Plate, K. H. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0483-6 · Cited by 383
Nogo limits neural plasticity and recovery from injury
Schwab, M. E., & Strittmatter, S. M. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.02.011 · Cited by 373
Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-γ
Lee, S. C., Dickson, D. W., Liu, W., & Brosnan, C. F. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90229-r · Cited by 354
Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes
Matute, C., Sánchez-Gómez, M. V., Martínez-Millán, L., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8830 · Cited by 352 · cited 1×
“Decreased uptake of glutamate by astrocyte transporters could also contribute to pathologically elevated levels of extracellular glutamate, which are directly toxic to oligodendrocytes, axons, and neurons (74).”
BackgroundBundesen, L. Q., Scheel, T. A., Bregman, B. S., & Kromer, L. F. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07789.2003 · Cited by 344
Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines
Balasingam, V, Tejada-Berges, T., Wright, E., Bouckova, R., & Yong, V. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-02-00846.1994 · Cited by 342
Argaw, A. T., Zhang, Y., Snyder, B. J., Zhao, M.-L., Kopp, N., Lee, S. C., Raine, C. S., Brosnan, C. F., & John, G. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5574 · Cited by 339
Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333 · cited 2×
“Notably, senescent astrocytes can repress their capacity to support neuronal survival and neurite outgrowth, causing changes resembling those observed in the SASP, namely (1) increased expression of GFAP and vimentin filaments (132, 133); (2) accumulation of membrane-bound inclusion material in cytoplasm that appears…”
BackgroundGeneral mechanisms of axonal damage and its prevention
Stys, P. K. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.031 · Cited by 314
Astrocytes in multiple sclerosis: A product of their environment
Nair, A., Frederick, T. J., & Miller, S. D. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8059-5 · Cited by 313
Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Multiple Sclerosis Lesions
Liu, J. S.-H., Zhao, M.-L., Brosnan, C. F., & Lee, S. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64677-9 · Cited by 311
Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS
EMSLEY, J. G., & MACKLIS, J. D. (2006) · Neuron Glia Biology · doi:10.1017/s1740925x06000202 · Cited by 303
Astrocytes—Friends or foes in multiple sclerosis?
Williams, A., Piaton, G., & Lubetzki, C. (2007) · Glia · doi:10.1002/glia.20546 · Cited by 302
Patel, T. B., & Clark, J. B. (1979) · Biochemical Journal · doi:10.1042/bj1840539 · Cited by 292
White matter astrocytes in health and disease
Lundgaard, I., Osório, M. J., Kress, B. T., Sanggaard, S., & Nedergaard, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.050 · Cited by 290
Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Li, C., Zhao, R., Gao, K., Wei, Z., Yaoyao Yin, M., Ting Lau, L., Chui, D., & Cheung Hoi Yu, A. (2011) · Current Alzheimer Research · doi:10.2174/156720511794604543 · Cited by 289
Mitochondrial Dysfunction and Glutamate Excitotoxicity Studied in Primary Neuronal Cultures
Nicholls, D. (2004) · Current Molecular Medicine · doi:10.2174/1566524043479239 · Cited by 272
The role of antigen presenting cells in multiple sclerosis
Chastain, E. M. L., Duncan, D. S., Rodgers, J. M., & Miller, S. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.008 · Cited by 266
Astrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease
DeWitt, D. A., Perry, G., Cohen, M., Doller, C., & Silver, J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6738 · Cited by 261 · cited 1×
“Fifth, astrocytes modulate microglial and macrophages activity through two different pathways: (a) inducing their recruitment toward lesion sites by producing chemotactic signals (CXCL-10CXCR3) (58) and (b) by secreting GM-CSF, M-CSF, or TGF-β, which can regulate Class II expression, and even microglial phagocytosis (…”
BackgroundFidler, P. S., Schuette, K., Asher, R. A., Dobbertin, A., Thornton, S. R., Calle-Patino, Y., Muir, E., Levine, J. M., Geller, H. M., Rogers, J. H., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08778.1999 · Cited by 261
Sriram, K., Benkovic, S. A., Hebert, M. A., Miller, D. B., & O'Callaghan, J. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309304200 · Cited by 261
The astrocyte in multiple sclerosis revisited
Brosnan, C. F., & Raine, C. S. (2013) · Glia · doi:10.1002/glia.22443 · Cited by 259
Karpus, W. J., & Ransohoff, R. M. (1998) · PubMed · Cited by 224
Didier, N., Romero, I. A., Créminon, C., Wijkhuisen, A., Grassi, J., & Mabondzo, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01829.x · Cited by 221
Structural Remodeling of Astrocytes in the Injured CNS
Sun, D., & Jakobs, T. C. (2012) · The Neuroscientist · doi:10.1177/1073858411423441 · Cited by 219
Reactive Nitrogen Intermediates in Human Neuropathology: An Overview
Brosnan, C. F., Battistini, L., Raine, C. S., Dickson, D. W., Casadevall, A., & Lee, S. C. (1994) · Developmental Neuroscience · doi:10.1159/000112102 · Cited by 209
Pathophysiology of astroglial purinergic signalling
Franke, H., Verkhratsky, A., Burnstock, G., & Illes, P. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9300-0 · Cited by 201
The cytokine IL‐1β transiently enhances P2X7 receptor expression and function in human astrocytes
Narcisse, L., Scemes, E., Zhao, Y., Lee, S. C., & Brosnan, C. F. (2005) · Glia · doi:10.1002/glia.20110 · Cited by 191
Karpus, W. J., & Ransohoff, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2667 · Cited by 189
The innate immune system in demyelinating disease
Mayo, L., Quintana, F. J., & Weiner, H. L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01135.x · Cited by 186
Glial cells more than support cells?
He, F., & Sun, Y. E. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.022 · Cited by 170
TIM-3 and Its Regulatory Role in Immune Responses
Zhu, C. Y., Anderson, A. C., & Kuchroo, V. K. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_84 · Cited by 169
Astrocyte characterization in the multiple sclerosis glial scar
Holley, J. E., Gveric, D., Newcombe, J., Cuzner, M. L., & Gutowski, N. J. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00491.x · Cited by 169
The mitochondrial permeability transition in neurologic disease
NORENBERG, M., & RAO, K. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.02.008 · Cited by 169
Nakazawa, T., Takeda, M., Lewis, G. P., Cho, K.-S., Jiao, J., Wilhelmsson, U., Fisher, S. K., Pekny, M., Chen, D. F., & Miller, J. W. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-1398 · Cited by 168 · cited 1×
“Thus, infiltration of CD11b+ microglia/monocytes in a retinal detachment model was blocked in GFAP−/− Vim−/− mice, suggesting activated glial cells are critical for recruitment of microglia/monocytes to injured areas (99).”
BackgroundCalderon, T. M., Eugenin, E. A., Lopez, L., Kumar, S. S., Hesselgesser, J., Raine, C. S., & Berman, J. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.003 · Cited by 168
Macvicar, B. A., Feighan, D., Brown, A., & Ransom, B. (2002) · Glia · doi:10.1002/glia.10023 · Cited by 167
Lee, H., Raiker, S. J., Venkatesh, K., Geary, R., Robak, L. A., Zhang, Y., Yeh, H. H., Shrager, P., & Giger, R. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5586-07.2008 · Cited by 164
Kanemaru, K., Kubota, J., Sekiya, H., Hirose, K., Okubo, Y., & Iino, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300378110 · Cited by 159
Zhou, Y., Sonobe, Y., Akahori, T., Jin, S., Kawanokuchi, J., Noda, M., Iwakura, Y., Mizuno, T., & Suzumura, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003307 · Cited by 150
Rossi, S., Motta, C., Studer, V., Barbieri, F. R., Buttari, F., Bergami, A., Sancesario, G. M., Bernardini, S., Angelis, G. D., Martino, G., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513498128 · Cited by 149
Selective Proinflammatory Activation of Astrocytes by High-Mobility Group Box 1 Protein Signaling
Pedrazzi, M., Patrone, M., Passalacqua, M., Ranzato, E., Colamassaro, D., Sparatore, B., Pontremoli, S., & Melloni, E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8525 · Cited by 140
Hippocampal aging in rats: A morphometric study of multiple variables in semithin sections
Landfield, P. W., Braun, L. D., Pitler, T. A., Lindsey, J. D., & LYNCH, G. S. (1981) · Neurobiology of Aging · doi:10.1016/0197-4580(81)90034-8 · Cited by 138
Erschbamer, M., Pernold, K., & Olson, L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1037-07.2007 · Cited by 132
Conditional deletion of β1‐integrin in astroglia causes partial reactive gliosis
Robel, S., Mori, T., Zoubaa, S., Schlegel, J., Sirko, S., Faissner, A., Goebbels, S., Dimou, L., & Götz, M. (2009) · Glia · doi:10.1002/glia.20876 · Cited by 130
TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation
Gimenez, M. A. T., Sim, J. E., & Russell, J. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.012 · Cited by 128
Korn, T., Magnus, T., & Jung, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3748fje · Cited by 127
Porchet, R., Probst, A., Bouras, C., Dráberová, E., Dráber, P., & Riederer, B. M. (2003) · PROTEOMICS · doi:10.1002/pmic.200300456 · Cited by 124
Toft‐Hansen, H., Füchtbauer, L. M., & Owens, T. (2010) · Glia · doi:10.1002/glia.21088 · Cited by 123
Rindfleisch, E. (1863) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01878008 · Cited by 115
Multiple Sclerosis Therapeutics
Rudick, R. A., & Cohen, J. A. (2018) · CRC Press eBooks · doi:10.3109/9780203639115 · Cited by 115
Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors
Keyser, J. D., Wilczak, N., Leta, R., & Streetland, C. (1999) · Neurology · doi:10.1212/wnl.53.8.1628 · Cited by 114
Robel, S., Bardehle, S., Lepier, A., Brakebusch, C., & Götz, M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2696-11.2011 · Cited by 110
Reichenbach, A., & Wolburg, H. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195152227.003.0002 · Cited by 109
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
Ouardouz, M., Coderre, E., Basak, A., Chen, A. A., Zamponi, G. W., Hameed, S., Rehak, R., Yin, X., Trapp, B. D., & Stys, P. K. (2009) · Annals of Neurology · doi:10.1002/ana.21533 · Cited by 108
Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
Ouardouz, M., Coderre, E., Zamponi, G. W., Hameed, S., Yin, X., Trapp, B. D., & Stys, P. K. (2009) · Annals of Neurology · doi:10.1002/ana.21539 · Cited by 107
Neuro–glia interaction effects on GFAP gene: a novel role for transforming growth factor‐β1
Spohr, T. C. L. D. S. E., Martinez, R., Silva, E. F. D., Moura‐Neto, V., & Gomes, F. C. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02283.x · Cited by 105
Contribution of Astrocyte-Derived IL-15 to CD8 T Cell Effector Functions in Multiple Sclerosis
Saikali, P., Antel, J. P., Pittet, C. L., Newcombe, J., & Arbour, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002188 · Cited by 101
Goddard, D. R., Berry, M., & Butt, A. M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990701)57:1<74::aid-jnr8>3.0.co;2-o · Cited by 98
Butt, A. M., Duncan, A., & Berry, M. (1994) · Journal of Neurocytology · doi:10.1007/bf01184072 · Cited by 97
Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes
Trajković, V., Stošić‐Grujičić, S., Samardžić, T., Marković, M., Miljković, D. M., Ramić, Z., & Stojković, M. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00391-5 · Cited by 97
The role of glutamate and its receptors in multiple sclerosis
Stojanović, I. R., Kostić, M. S., & Ljubisavljević, S. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1188-0 · Cited by 93
TROY and LINGO‐1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions
Satoh, J., Tabunoki, H., Yamamura, T., Arima, K., & Konno, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00787.x · Cited by 93
Sloane, J. A., Hollander, W., Rosene, D. L., Moss, M. B., Kemper, T. L., & Abraham, C. R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02059-x · Cited by 92
Oligodendrocyte precursor cells: Reactive cells that inhibit axon growth and regeneration
Chen, Z. J., Negra, M., Levine, A. K., Ughrin, Y., & Levine, J. M. (2002) · Journal of Neurocytology · doi:10.1023/a:1025791614468 · Cited by 91
Zhang, L., Zheng, S., Wu, H., Wu, Y., Liu, S., Fan, M., & Zhang, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5040-08.2009 · Cited by 88
Role of glia-derived cholesterol in synaptogenesis: new revelations in the synapse–glia affair
Göritz, C., Mauch, D. H., Nägler, K., & Pfrieger, F. W. (2002) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(02)00014-1 · Cited by 88
Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules
Zeinstra, E., Wilczak, N., Streefland, C., & Keyser, J. D. (2000) · Neuroreport · doi:10.1097/00001756-200001170-00018 · Cited by 87
Hamby, M. E., Hewett, J. A., & Hewett, S. J. (2006) · Glia · doi:10.1002/glia.20411 · Cited by 87
Salmaggi, A., Gelati, M., Dufour, A., Corsini, E., Pagano, S., Baccalini, R., Ferrero, E., Scabini, S., Silei, V., Ciusani, E., et al. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260100114 · Cited by 82
LGI1 Is a Nogo Receptor 1 Ligand that Antagonizes Myelin-Based Growth Inhibition
Thomas, R. A., Favell, K., Morante‐Redolat, J. M., Pool, M., Kent, C., Wright, M., Daignault, K., Ferraro, G. B., Montcalm, S., Durocher, Y., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5147-09.2010 · Cited by 81
Characterization of glycosaminoglycans produced by primary astrocytes in vitro
Johnson-Green, P., Dow, K. E., & Riopelle, R. J. (1991) · Glia · doi:10.1002/glia.440040309 · Cited by 79
Hatada, I., Namihira, M., Morita, S., Kimura, M., Horii, T., & Nakashima, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003189 · Cited by 79
Miyake, Y., & Yamasaki, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1680-7_9 · Cited by 78
Washburn, K. B., & Neary, J. T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.034 · Cited by 72
Ephrin A Receptors and Ligands in Lesions and Normal-Appearing White Matter in Multiple Sclerosis
Sobel, R. A. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00098.x · Cited by 71
Pannu, R., Won, J., Khan, M., Singh, A. K., & Singh, I. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1271-04.2004 · Cited by 71
Kumar, P., Kalonia, H., & Kumar, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.11.030 · Cited by 70
Astrocyte-induced T cell elimination is CD95 ligand dependent
Bechmann, I., Steiner, B., Gimsa, U., Mor, G., Wolf, S. A., Beyer, M., Nitsch, R., & Zipp, F. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00311-9 · Cited by 70
Multiple nicht eitrige Encephalomyelitis und multiple Sklerose
Anton, G., & Wohlwill, F. (1912) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02866371 · Cited by 66
Astrocytic β2-adrenergic receptors and multiple sclerosis
Keyser, J. D., Zeinstra, E., & Wilczak, N. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.012 · Cited by 64
The histopathology of grey matter demyelination in multiple sclerosis
Bø, L. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01216.x · Cited by 58
The p75 receptor mediates axon growth inhibition through an association with PIR-B
Fujita, Y., Takashima, R., Endo, S., Takai, T., & Yamashita, T. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.85 · Cited by 58
Kort, J., Kawamura, K., Fugger, L. H., Weissert, R., & Forsthuber, T. G. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.014 · Cited by 58
Nitric oxide synthase expression and enzymatic activity in multiple sclerosis
Broholm, H., Andersen, B., Wanscher, B., Frederiksen, J. L., Rubin, I., Pakkenberg, B., Larsson, H. B. W., & Lauritzen, M. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00207.x · Cited by 53
Hyaluronate‐based extracellular matrix: Keeping glia in their place
Sherman, L. S., Struve, J. N., Rangwala, R. A., Wallingford, N. M., Tuohy, T. M. F., & Kuntz, C. (2002) · Glia · doi:10.1002/glia.10053 · Cited by 52
The Nogo-66 receptor family in the intact and diseased CNS
Borrie, S. C., Baeumer, B. E., & Bandtlow, C. E. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1332-9 · Cited by 52
Liu, J.-Q., Carl, J. W., Joshi, P. S., Ray‐Chaudhury, A., Pu, X.-A., Shi, F., & Bai, X. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6227 · Cited by 49
Astrocytes stimulate interleukin‐17 and interferon‐γ production in vitro
Miljković, D. M., Momčilović, M. B., Stojanović, I., Stošić‐Grujičić, S., Ramić, Z., & Mostarica‐Stojković, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21453 · Cited by 49
HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis
Sun, Y., Chen, H., Dai, J., Zou, H., Gao, M., Wu, H., Ming, B., Lai, L., Xiao, Y., Xiong, P., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.02.005 · Cited by 44
Multiple Sclerosis – A Comprehensive Text.
Jellinger, K. A. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02420.x · Cited by 42
Multiple Sclerosis Therapeutics
(2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986 · Cited by 39
Hyaluronate receptor (CD44) and integrin α4 (CD49d) are up-regulated on T cells during MS relapses
Soilu‐Hänninen, M., Laaksonen, M., & Hänninen, A. L. M. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.05.008 · Cited by 19
Cited by
Multiple sclerosis progression: time for a new mechanism-driven framework
Kuhlmann, T., Moccia, M., Coetzee, T., Cohen, J. A., Correale, J., Graves, J., Marrie, R. A., Montalban, X., Yong, V. W., Thompson, A. J., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00289-7 · Cited by 667
Self-citationProgressive multiple sclerosis: from pathogenic mechanisms to treatment
Correale, J., Gaitán, M. I., Ysrraelit, M. C., & Fiol, M. P. (2016) · Brain · doi:10.1093/brain/aww258 · Cited by 573
Self-citationOligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair
Domingues, H. S., Portugal, C. C., Socodato, R., & Relvas, J. B. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00071 · Cited by 432
Serum GFAP as a biomarker for disease severity in multiple sclerosis
Abdelhak, A., Huss, A., Kassubek, J., Tumani, H., & Otto, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-33158-8 · Cited by 291
Perriot, S., Mathias, A., Perriard, G., Canales, M., Jonkmans, N., Merienne, N., Meunier, C., El Kassar, L., Perrier, A. L., Laplaud, D.-A., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.09.015 · Cited by 171
Metadata
- Authors
- Correale, J., & Farez, M. F.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2015-08-18
- Volume
- 6
- Pages
- 180-180
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W1834417670
- Cited by
- 261
- References
- 139
- FWCI
- 16.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.